FONDAPARINUX IN THE TREATMENT OF ACUTE CORONARY SYNDROME
Fondaparinux is a parenteral selective factor-Xa inhibitor. The drug is successfully used in the treatment of acute coronary syndrome, and is characterized by the ideal profile of effectiveness and safety. In the case of ACS without ST-segment elevation, fondaparinux is the drug of choice regardless...
Saved in:
| Main Author: | |
|---|---|
| Format: | Book |
| Published: |
«REMEDIUM GROUP» Ltd.,
2017-05-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Internet
Connect to this object online.3rd Floor Main Library
| Call Number: |
A1234.567 |
|---|---|
| Copy 1 | Available |